Skip to main content
. 2017 Aug 4;8(43):73387–73406. doi: 10.18632/oncotarget.19945

Table 3. CXCR4 expression on metastatic lesions, organized by primary cancers.

Primary cancers Total samples Positive for CXCR4 Positive for CXCR4 (%)
Adenocarcinoma of unknown site 18 5 28
Breast, carcinoma 9 3 33
Colon, carcinoma 47 5 11
Colon, mucinous carcinoma 5 1 20
Colon, signet ring cell carcinoma 4 1 25
Colon, squamous carcinoma 1 1 100
Esophagus, squamous carcinoma 3 2 67
Gastric carcinoma 3 0 0
Kidney, clear cell carcinoma 7 4 57
Kidney, carcinoma, type not specified 1 1 100
Kidney, sarcomatoid carcinoma 1 0 0
Larynx, squamous carcinoma 1 1 100
Liver, hepatocellular carcinoma 2 0 0
Lung, adenocarcinoma 1 1 100
Lung, squamous cell carcinoma 3 3 100
Melanoma 12 1 8
Nasopharynx, carcinoma 4 4 100
Ovary, mucinous cystadenocarcinoma 1 0 0
Pancreas, carcinoma 1 0 0
Penis, squamous carcinoma 1 0 0
Rectum, carcinoma 7 0 0
Rectum, mucinous carcinoma 1 0 0
Squamous cell carcinoma of unknown site 4 4 100
Thyroid, follicular carcinoma 1 0 0
Thyroid, papillary carcinoma 4 1 25
All samples 142 38 27